FDA
- Status: approved
Adductor canal regional block (Adductor canal regional block) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
Icahn School of Medicine at Mount Sinai is the originator. The local marketing authorisation holder may differ — check the official source linked above.